Wave Life Sciences (WVE) Capital Leases (2015 - 2016)
Wave Life Sciences' (WVE) quarterly Capital Leases came in at $16000.0 in Q4 2016, down 79.49% YoY from $78000.0 in Q1 2016, and down 48.39% on a QoQ basis from $31000.0 in Q3 2016.
Wave Life Sciences (WVE) Capital Leases (2015 - 2016) Analysis & Trends
Wave Life Sciences (WVE) has 2 years of Capital Leases data on file, last reported at $16000.0 in Q4 2016.
- Quarterly Capital Leases fell 79.49% year-over-year to $16000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $16000.0 (down 79.49% YoY) and the FY2016 annual result came in at $16000.0, down 79.49% from the prior year.
- Capital Leases retreated to $16000.0 in Q4 2016, from $31000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $94000.0 in Q3 2015 to a low of $16000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 16,000.00 |
| Sep 30, 2016 | 31,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | 78,000.00 |
| Sep 30, 2015 | 94,000.00 |